## Note
nid: 1514568850106
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step1_v11::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antimycobacterial_Therapy, #AK_Step1_v11::#FirstAid::03_Microbiology::07_Antimicrobials::27_Rifamycins, #AK_Step1_v11::#OME_banner::Basic_Science::08_Microbiology::20_Antimycobacterials, #AK_Step1_v11::#SketchyPharm::07_Antimicrobials::03_Antimycobacterials::01_Tuberculosis_Drugs::zanki_extra, #AK_Step1_v11::$AnKingUpdates::$Errata::v11, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^FA_Updates::FA2018, #AK_Step1_v11::^Other::^HighYield::3-HighYield-temporary
markdown: false

### Text
Which one of the following drugs is a <i>major</i> <u>cytochrome
p450</u> <b>inducer?</b>
<div>
  <b>{{c1::Rifampin}}</b>
</div>
<div><img src="paste-718749892083713.jpg"></div>

### Extra
<div>
  - Rifampin also induces <b>UDP-Glucuronyltransferase</b> (Phase
  II Metabolism)
</div>- Thus use <b>Rifabutin</b> (does not stimulate / inhibit
cyp450) in patients with <u>HIV infection</u> (ex when treating a
MAC infection) as certain HIV drugs are metabolized by cyp450 (ex.
<b>Protease inhibitors</b>)
<div><img src="paste-720330440048641.jpg"></div>
<div><img src="paste-285207303290881.jpg"></div>
<div><img src="paste-122917669044225.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-457907938263043.jpg"><img src=
"paste-461352502034435.jpg"><img src="paste-463057604050947.jpg">
<div><img src="paste-174826643783683.jpg"></div>

### Sketchy
<img src="paste-235686330368001.jpg"> <img src=
"paste-66c7354fc8106dbad422fb1cb1261f23fc1634e3.png">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/microbiology/antimycobacterials/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_5.png"></a>
</div>

### Additional Resources


### One by one

